Kohl' Says Activist Investors' Proposals Threaten To Disrupt Its Business Momentum

Kohl's Corp. (KSS) said that Activist Investors are focused on short-termism and financial engineering at the expense of sustainable operating and financial success. They also propose certain ideas that the Company already has well underway. The company rejected their attempt to disrupt the company's strong business momentum.

Earlier today, the Investor Group, which owns about 9.5% of Kohl'soutstanding common stock, said that it filed revised preliminary proxy materials announcing its slate of five directors to run in opposition to five of the company's long tenured directors who the Investor Group believes do not have the relevant retail and governance skills to create shareholder value.

The Investor Group believes board refreshment is essential to driving increased value creation for all Kohl's shareholders.

The Investor Group's slate of nominees consists of Jonathan Duskin, Margaret Jenkins, Jeffrey Kantor, Thomas Kingsbury and Cynthia Murray.

The Investor Group consist of Macellum Advisors GP LLC, Ancora Holdings Inc., Legion Partners Asset Management LLC, and 4010 Capital, LLC.

Meanwhile Kohl's said its directors outmatch the Activist Investors' slate of nominees on relevant experience.

Kohl's said that the Activists' slate lacks critical relevant experience. One of their nominees has presided over four companies that filed for bankruptcy. Three of their five nominees have not served on boards of retail companies of a comparable size to Kohl's. Two of the nominees have never served on a public company board. Four of five of the Activists' nominees lack meaningful digital experience.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT